1990
DOI: 10.1111/j.1749-6632.1990.tb31999.x
|View full text |Cite
|
Sign up to set email alerts
|

Second Messengers Are Involved in Facilitatory but Not Inhibitory Receptor Actions at Sympathetic Nerve Endings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

1992
1992
2003
2003

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 29 publications
0
8
0
Order By: Relevance
“…This pattern of effects was distinct from that observed upon activation of release enhancing b 2 -adrenoceptors, known to be coupled to G s -adenylate cyclase-protein kinase A pathway (Sibley and Lefkowitz 1987;Majewski et al 1990), or upon direct activation of adenylyl cyclase. a 2 -adrenoceptors, adenosine A 1 and P2Y receptors).…”
Section: Discussionmentioning
confidence: 74%
“…This pattern of effects was distinct from that observed upon activation of release enhancing b 2 -adrenoceptors, known to be coupled to G s -adenylate cyclase-protein kinase A pathway (Sibley and Lefkowitz 1987;Majewski et al 1990), or upon direct activation of adenylyl cyclase. a 2 -adrenoceptors, adenosine A 1 and P2Y receptors).…”
Section: Discussionmentioning
confidence: 74%
“…PKC is one of the intracellular effectors involved in the action of facilitatory prejunctional receptors of sympathetic nerve endings (Majewski et al, 1990). Indeed, the involvement of this protein kinase in the S-I release of NA has been shown in different experimental preparations, including rabbit hippocampus (Allgaier & Hertting, 1986), cat cerebral arteries (Balfagon et al, 1989), rat salivary gland (Wakade et al, 1985) and rat atria (Ishac & De Luca, 1988).…”
Section: Discussionmentioning
confidence: 99%
“…The intracellular effectors involved in the action of many facilitatory prejunctional receptors of peripheral sympathetic nerve terminals are either adenylate cyclase or protein kinase C (PKC) (Majewski et al, 1990).…”
Section: Introductionmentioning
confidence: 99%
“…A dose-dependent facilitatory effect of cell-permeable cAMP analogues has been previously observed in mouse atria42 and the human pulmonary artery.43 It has been suggested that the facilitatory effect of f3-adrenergic receptor activation on norepinephrine release is linked to stimulation of adenylate cyclase and, hence, an increased formation of cAMP. 44 In the present study, a combination of 8-bromo-cAMP and the nonselective phosphodiesterase inhibitor IBMX45 was used to test this hypothesis. If intraneuronal levels of 8-bromo-cAMP and endogenous cAMP were already maximally increased, then isoproterenol should not be able to enhance neurotransmitter release through a cAMP-dependent mechanism.…”
Section: Camp and Norepinephrine Releasementioning
confidence: 98%